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Prostaglandin E2 stimulates expression of matrix metalloproteinase 2
in cultured rat mesangial cells. Prostaglandins of the E-series have been
demonstrated to reduce extracellular accumulation of collagens in some
models of glomerulonephritis. This effect is partially due to reduction of
collagen formation by mesangial cells. The potential effects of prostaglan-
dins on the expression of collagen degrading enzymes in mesangial cells
are largely unknown. Since rat mesangial cells generate a matrix metallo-
proteinase 2 (MMP-2) that specifically degrades collagen type IV, the
effects of prostaglandin E2 (PGE2) on transcription, steady-state mRNA
levels, extracellular enzyme activity and protein concentration of this
proteinase were evaluated. Mesangial cells (MC) were incubated with
PGE2 (2 LM) for different time-periods (1 to 48 hr), and steady-state
mRNA levels of MMP-2 were determined by Northern blotting. PGE2
increased MMP-2 mRNA levels beginning at one hour of incubation and
remained elevated up to 24 hours. Nuclear run off experiments revealed
that the PGE2-induced increase in mRNA expression for MMP-2 is due to
stimulated gene transcription. Western blot analysis and zymography
revealed that MMP-2 protein production and enzyme activity was also
enhanced by PGE2. The cAMP analogue 8-bromo-cAMP increased
MMP-2 mRNA levels, suggesting that PGE2-induced generation of intra-
cellular cAMP plays a role in MMP-2 induction in MC. These studies
demonstrate that PGE2 stimulates the transcription, protein formation
and enzyme activity of MMP-2 in cultured rat MC. This effect may
contribute to the prostaglandin mediated reduction of extracellular colla-
gen deposition in glomerulonephritis.
Prostaglandin E2 (PGE2) formation is increased in various
immune [1—31 and nonimmune [4] glomerulopathies. Together
with prostacyclin, PGE2 partly counteracts vasoconstrictive pep-
tide hormones [51 to maintain glomerular filtration [3, 41. Besides
these important hemodynamic functions prostaglandins of the E
series ameliorate glomerular structural damage in immune-medi-
ated experimental diseases by reducing glomerular immune-
complex deposition and inhibition of the infiltration of inflamma-
tory cells [6—9].
In the glomerulus the mesangial cells (MC) are a primary target
for vasoactive hormones, various cytokines, growth factors and
prostaglandins [10]. MC are also a source of extracellular matrix
proteins whose overproduction in pathology can contribute to
glomeruloscierosis and loss of glomerular function [11—13].
Received for publication April 4, 1996
and in revised form September 16, 1996
Accepted for publication October 14, 1996
© 1997 by the International Society of Nephrology
Earlier in vitro studies in MC have shown that PGE2 and
prostacyclin exert antiproliferative effects [14, 15], suggesting that
these prostanoids are involved in the growth regulation of resident
glomerular cells. Furthermore, PGE2 decreases the gene-expres-
sion of collagens in cultured rat MC [16] and might contribute to
the reconstruction of injured glomeruli. This potential therapeutic
effect of prostanoids might, however, not only include the reduc-
tion of collagen synthesis, but also affect matrix degradation.
MC generate a 72 kDa collagenase (matrix metalloprotein-
ase-2, MMP-2) that specifically degrades collagen type IV [17—19].
This MMP-2 belongs to the group of proteinases that is secreted
as a proenzyme and need zinc and neutral pH for maximal activity
[20—22]. Proteinases might play a role in the reconstruction of
injured glomeruli in glomerulonephritis. Thus, the possibility
exists that POE2 stimulates the formation of enzymes that de-
grade extracellular matrix, resulting in an overall reduced depo-
sition of extracellular matrix proteins into the mesangial space. To
test this hypothesis, we studied the effect of PGE2 on the mRNA
expresssion, protein synthesis and enzyme activity of MMP-2 in
cultured rat MC.
Our data demonstrate that POE2 stimulates transcription of the
MMP-2 gene resulting in an increase in steady-state mRNA levels
as well as in an increase in extracellular protein levels and enzyme
activity.
Methods
Cell culture
MC cultures were established from glomeruli isolated from
kidneys of male Sprague-Dawley rats (80 to 100 g body wt) by
differential sieving as previously described [15]. Collagenase
treated glomeruli were plated on culture dishes (Nunc, Roskilde,
Denmark) in RPMI-1640 media containing 10% heat-inactivated
fetal calf serum (FCS; Gibco, Eggenstein, Germany), 100 U/mI
penicillin, 100 jtg/ml streptomycin, and 0.66 U/ml bovine insulin
(Gibco). Immunofluorescent staining of the cells was positive with
antibodies against myosin, smooth muscle cell actin, desmin, and
Thy 1.1. The cells did not stain for Factor VIII and rat common
leukocyte antigen. MC cultures were maintained at 37°C in 5%
CO2 in air and passaged with trypsin-EDTA (Gibco) 10 to 14 days
after the initial plating. Subcultures were made at 10 to 14 day
intervals. All experiments were performed on subcultures 20 to
35.
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Isolation of total RNA, and nonradioactive Northern blot
hybridization
To test the effect of PGE2 on steady-state mRNA levels for
MMP-2, rat MC were incubated for 1 to 48 hours in serum-free
RPMI-1640 with 2 jiM PGE2 (BioScience, Emmenbruecke, Swit-
zerland) redissolved in ethanol, Controls were treated with sol-
vent only. To evaluate the possible role of cAMP, MC were also
incubated 0.5 to 24 hours with 1 mivi 8-bromo-cAMP (8-br-cAMP;
Sigma, Munich, Germany). To examine whether endogenous
prostaglandins play a role on MMP-2 mRNA expression, MC
were also treated 16 hours with 5 jig/ml indomethacin. At the end
of the stimulation period, cell layers were washed twice with
sterile phosphate-buffered saline (PBS, pH 7.2), and cells were
directly solubilized in S ml of a buffer containing 4 M guanidine
isothiocyanate, 25 m sodium citrate (pH 7.0), 0.5% sodium
lauroyl-sarcosinate, and 0.7% -mercapto-ethanol. RNA was
extracted by repetitive phenol-chloroform-extraction and was
precipitated with ice-cold isopropanol [23]. The quantity and
purity of the preparations were assessed by measurement of
absorption at 260 and 280 nm. To separate total RNA, 20 jig/lane
was denatured in formamide-fromaldehyde and loaded onto a
1.2% agarose gel containing 2.2 M formaldehyde. The RNA was
vacuum blotted to a nylon membrane (Zetabind; Cuno, Meriden,
CT, USA) and shortwave UV-cross-linked. Prehybridization was
carried out at 42°C for one hour in 1 M NaCI, 1% SDS, 6% PEG
6000, 50% Formamid and 250 jig/mi sonicated and heat-deriatur-
ated salmon sperm DNA. Then 50 ng of a heat-denatured
biotinylated 756 bp rat MMP-2 cDNA fragment was added and
hybridized overnight at 42°C. The membranes were washed once
in 2 X SSPE, 0.5% SDS (20 X SSPE: 3.6 M NaCI, 0.2 M sodium
phosphate buffer, pH 7.4, 20 mrvi EDTA) for 30 minutes at room
temperature, and subsequently once in 0.2 x SSPE, 0.5% SDS for
one hour at 60°C. Detection of the biotinylated hybrids were
performed with a chemoluminescence based Northern hybridiza-
tion detection kit (Tropix, Bedford, MA, USA) according to the
manufacturers protocol. X-ray films (Hyperfilm ECL; Amersham)
were exposed 0.5 to 2 hours at room temperature without
intensifying screen. The membranes were stripped for one hour in
5 mM Tris-HCI, pH 8.0, 0.5% sodium pyrophosphate, 5 ><
Denhardt's (100 x Denhardt's: 2% Ficoll 400, 2% polyvinylpyr-
rolidone, 2% BSA), and 0.2 mrvi EDTA at 65°C and rehybridized
with a biotin labeled 2.0 kb human cDNA probe of 18S rRNA (a
gift from Dr. N. Reindl, Erlangen, Germany) or with a biotin
labeled 0.58 kb EcoRI cDNA fragment of rat GAPDH [241 to
account for small RNA loading and transfer variabilities. Exposed
films were scanned with a laser densitometer connected to a
computer system (Hoefer Scientific Instruments, San Francisco,
CA, USA). The intensities of the hybridization signals were
normalized to 18S rRNA or GAPDH.
To generate a rat MMP-2 cDNA probe 10 jig of rat MC total
RNA were reverse transcribed with 10 jil 5 x first strand buffer,
2.5 jil of a dNTP-mix (20 mM), 40 U RNasin (Promega, Madison,
WI, USA), 50 ng Poly-dT-primer (Pharmacia, Freiburg, Germa-
ny), and 5 U of M-MLV Reverse Transcriptase (Gibco) for two
hours at 37°C. Subsequently 5 jil of the cDNA preparation was
directly used for the PCR amplification with 5 jil 10 X amplifi-
cation buffer, 3 jil MgCl2 (25 mM), 4 pi dNTPs (10 mM), 1.5 jil (50
ng/jil) sense- and 1.5 jil (50 ng/jil) antisense-primer specific for
rat MMP-2 and 2.5 U Taq-polymerase (Promega). A total of 40
amplification cycles (denaturing for 30 seconds at 94°C, annealing
for 90 seconds at 62°C, and extension for 90 seconds at 72°C) were
performed. The following specific primers for rat MMP-2 were
used:
Sense: 5' CCA.GCG.ACC.TCA.GGG.TGA.ACA 3'
Antisense: 5' TAG.TGG.AGC.ACC.AGA.GGA.A 3' [25, 26].
One microliter of the amplified eDNA was directly ligated into
a cloning vector (TA-Vector; Invitrogen, San Diego, CA, USA)
and transformed in competent E. coli NM 522 cells. The cloned
eDNA was sequenced to confirme idendity with the published
MMP-2 sequence [25, 26]. Biotinylation of the eDNA probe was
performed by cDNA amplification. Ten nanograms of rat MMP-2
plasmid DNA, 4 jil of a dNTP mix containing 10 mvi biotin
16-dUTP (Boehringer, Mannheim, Germany) instead of dTTP,
1.5 jil (50 ng/jil) sense and 1.5 jil (50 ng/jil) antisense primer were
mixed with the remaining components (described above). The two
primers were located upstream (sense) and downstream (anti-
sense) of the TA-Vector cloning site (antisense TA-primer: 5'
CGC.CAG.TGT.GAT.GGA.TA 3' and sense TA-primer: 5' AG-
T.AAC.GGC.CGC.CAG.TG 3'). Forty amplification cycles con-
sisting of 30 seconds at 94°C, 90 seconds at 50°C and 90 seconds
at 72°C were performed. The biotinylated cDNA fragment was
run on a 1.5% agarose gel and purified. The biotinylated cDNA
probe was stored at 10 ng/ml in 1 >< TE (10 X TE: 100 mvi
Tris-HCI, pH 7.5, 10 mvi EDTA) at 4°C and was stable for three
months.
Nuclear run off experiments
Confluent, quiescent rat MC (2 to 3 X iO cells) were treated
with or without 2 jiM PGE2 in serum-free RPMI-1640 medium for
one hour. MC were harvested in PBS and cells were lysed in a lysis
buffer containing 50 m'vi Tris-HCI, pH 8.0; 100 mvi NaCl, 5 mM
MgCl2 and 0.5% (vol/vol) Nonidet P-40 for five minutes on ice.
After one wash in lysis buffer, nuclei were resuspended in 100 pJ
storage buffer [50 m'vi Tris-HC1, pH 8.3; 5 mi MgCl2, 0.1 mM
EDTA, 40% (vol/vol) glycerol], and immediately frozen in liquid
nitrogen [23]. Nuclear run off transcription assays were done with
slight modifications as described before [27]. In brief, frozen
nuclei were thawed on ice and 2 >< transcription buffer (10 mM
Tris-HC1, pH 8.0; 300 mvi KC1, 5 mti MgCI2, 5 mM D]IT, 4 mM of
each ATP, GTP and CTP, and 30 nmol biotin 16-UTP; Boehr-
inger) were added and nascent RNA transcript run offs were
allowed for 30 minutes at 30°C. Then nuclei were digested first for
five minutes at 30°C with 100 U RNAse-free DNAse I (Gibco) by
adding 300 jil DNAse I buffer (20 mrvi HEPES, pH 7.5; 5 mM
MgCl2, 1 mi CaCI2), then 100 jil proteinase-K buffer (0.5 M
Tris-HC1, pH 7.4, 125 m EDTA, 5% SDS) and 5 jil proteinase
K (20 mg/mI; Sigma) were added for 30 minutes at 42°C. RNA was
extracted by repetitive phenol-chloroform extraction and precip-
itated with ice cold isopropanol. Precipitated RNA was recovered
in DEPC-treated distilled water, denatured by heating at 65°C for
five minutes and hybridized for 24 hours at 65°C in a hybridization
buffer consisting of 0.5 M sodium phosphate buffer (pH 7.2) and
7% SDS to 5 jig cDNA immobilized on a nylon membrane
(Zetabind; Cuno). The following cDNA probes were used: the
752 Bp fragment of rat MMP-2, a 6.3 kb human genomic GAPDH
fragment (ATCC, Rockville, MD, USA), and the Bluescript
vector (Stratagene, La Jolla, CA, USA). The membranes were
treated for 30 minutes at room temperature with 50 jig/ml
RNAse-A (Pharmacia, Freiburg, Germany) in RNAse-A buffer
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3.1 kb •—" MMP-2
18 S Fig. 1. Incubation of rat MC in culture with
PGE2 (2 p.t) between 1 to 48 hours strongly
stimulates the specific MMP-2 steady-state mRNA
at 3.1 kb up to 16 hours. At later timepoints the
MMP-2 mRNA level attenuates and reaches
control values.
(10 ms's Tris-HCI, pH 7.5, 5 ms's EDTA, 300 mss NaC1) to digest
unbound RNA. The subsequent wash of the membranes and
detection of the biotinylated hybrids were described above.
Generation of a rabbit-anti-human MMP-2 antibody
A polyclonal anti-human MMP-2 antiserum was induced in
rabbits by repetitive s.c. injection of 625 xg of human MMP-2 [28]
as antigen in 250 p.l sterile H20 and 250 .tl of Hunter's Titer Max
(Serva, Heidelberg, Germany). The rabbit was sacrificed one week
after the last injection and IgG was purified by using a protein A
column IgG purification kit (Pierce, Rockford, IL, USA) accord-
ing to the manufacturer's instructions.
This antibody also detects rat MMP-2. The antiserum is specific
for MMP-2, since Western blots show only a single band at 72 kDa
and preimmune serum does not detect this protein.
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Western blot analysis of MC culture supernatants
For Western blot analysis confluent and quiescent MC were
treated with 2 M PGE2 for 4 and 16 hours. Equal amounts of
supernatant were concentrated using Microcon-lO concentrators
(Amicon, Beverly, MA, USA). Then, 2 X Laemmli buffer (250 mM
Tris-HCI, pH 6.8, 2 s's /3-mercaptoethanol, 10% glycerol, 0.2%
bromphenolblue) was added to the concentrated supernatant.
Samples were boiled for 10 minutes and then cooled on ice. The
solution was loaded onto a 8% polyacrylamide SDS gel [291 and
electrophoresed at a constant current of 20 mA for four hours. A
molecular-weight marker (Amersham), which compromise 14.3 to
200 kDa, served as the molecular weight standard. After comple-
tion of electrophoresis, proteins were electroblotted semi-dry
(anode buffer I: 30 ms's Tris, 20% methanol; anode buffer II: 300
ifiM Tris, 20% methanol; cathode buffer: 25 ms's Tris, 40 mM
6-aminohexane acid, 20% methanol) for 50 minutes at 1 mAJcm2
onto a nitrocellulose membrane (Hybond ECL; Amersham). The
membrane was blocked in 5% nonfat dry milk in washing buffer
(1 x PBS, 0.1% Tween 20) for one hour at room temperature,
then incubated for another hour with the rabbit-anti-human-
MMP-2 IgG at a concentration of 1:200 in the same buffer. After
0
C00
1 hr 4hr l6hr 24hr 48hr
18 S
16 hr
Fig. 2. In a dose response experiment PGE2 stimulates MMP-2 steady-state
mRNA expression at a concentration of 2 p and 200 nM. No stimulation is
detectable at a PGE2 concentration of 20 nM when compared to untreated
control MC.
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Concentration
Time
hours
x-fold vs.
control
Time course (Fig. 1)
PGE2 2 x 106 M 1
4
16
24
48
2.6 0.6
2.0±0.4
2.7 0.7
1.5 0.4
1.1 0.1
Dose response curve (Fig. 2)
PGE2 2>< 10 M2 X i0 M
2 x iO M
16
16
16
2.5 0.2
2.4 0.1
1.0 0.2
Effect of Indomethacin (Fig. 3)
PGE2 2 x 10 M 16 2.0 0.1
Indomethacin 5 g/ml 16 1.1 0.05
Indomethacin 5 jg/ml 16 2.1 0.3
+PGE2 + 2 X 106 M
Effect of 8-br-cAMP (Fig. 4)
8-br-cAMP 1 mrvi 1
4
16
24
1.5 0.3
1.4±0.1
1.5±0.4
1.7 0.1
rinsing the membrane in washing buffer for 2 X 10 minutes, a
anti-rabbit-IgG antibody conjugated to horseradish-peroxidase
(Southern Biotechnology, Birmingham, Al, USA) was added at a
concentration of 1:2000 for one hour at room temperature. The
luminescence detection of peroxidase was performed with the
ECL system (Amersham) according to the manufacturer's recom-
mendations. Films were exposed for 1 to 15 minutes at room
temperature and exposed films were scanned with a laser densi-
tometer connected to a computer system (Hoefer Scientific
Instruments).
Zymography of MC culture supernatants
Confluent, quiescent rat MC in six-well plates were treated with
or without 2 LM PGE2 for 4 and 16 hours. Zymography was
performed according to a technique described by Marti et al 261.
Briefly, 5 p1 of 5 x gel loading buffer (0.5 M Tris-HC1, pH 6,8, 10%
SDS, 50% glycerol, 0.5% bromphenolblue) was added to 20 1td of
cell supernatant. Electrophoresis was performed through a 0.5
mm thick 8% polyacrylamide/SDS gel containing 1 mg/ml gelatine
(Sigma) as a substrate. After electrophoresis the gels were incu-
bated in 2.5% Triton X-100 for one hour at room temperature
and then for 18 hours at 37°C in a collagenase buffer containing
100 mM Tris-HCI, pH 7.9, 30 mivi CaC12, and 1 I.tM ZnC12. The gels
were stained with Coomassie blue, destained and photographed.
Results
Effect of PGE2 on MMP-2 steady-state mRNA levels
To examine the effect of PGE2 on the steady-state mRNA
levels of MMP-2, confluent and quiescent rat MC were treated for
I to 48 hours with 2 .tM PGE2. Beginning at one hour with a
maximum at 16 hours MMP-2 mRNA levels increased in POE2
treated cells (2.7-fold 0.7; Fig. 1) when compared to untreated
control MC. At 24 hours and 48 hours, MMP-2 mRNA expression
returned to control levels (1.1-fold 0,1; Fig. 1).
In a dose response experiment POE2 concentrations from 2 X
16 hr
Fig. 3. The cyclooxygenase inhibitor indomethacin (5 pg/mI) does not
significantly influence MMP-2 mRNA expression after 16 hours, whereas
PGE2 (2 p.sl) increased MMP-2 mRNA levels. The combination of indo-
methacin (5 jsg/ml) and PGE2 (2 M) exerts comparable results to the
treatment with PGE2 alone.
106 to 2 X 10 M were studied at 16 hours. As depicted in
Figure 2 PGE2 stimulates MMP-2 steady-state mRNA expression
2.5-fold at POE2 concentration of 2 X 10_6 M (Table 1). At a
concentration of 2 X i0 M MMP-2 steady-state mRNA expres-
sion was no longer different from control cells.
Effect of indomethacin on MMP-2 steady-state mRNA expression
To further study whether the formation of endogenous prosta-
glandins could influence MMP-2 steady-state mRNA expression
in rat MC, quiescent cells were treated for 16 hours in the
presence or absence of POE2 with 5 j.Lg!ml of the cyclooxygenase
inhibitor indomethacin. PGE2 alone increased MMP-2 mRNA
levels whereas indomethacin treatment had no significant effect
on MMP-2 expression levels (Fig. 3). In addition the combination
of POE2 and indomethacin increased MMP-2 mRNA levels
comparable to the POE2 treatment alone (Fig. 3).
Effect of 8-br-cAMP on MMP-2 steady-state mRNA levels
Since some PGE2 effects are mediated through the cAMP
dependent signal transduction pathway, it is of potential interest
whether the PGE2 effect on MMP-2 gene expression is also
mediated by cAMP. Therefore, the stable cAMP analogue 8-br-
cAMP on MMP-2 steady-state mRNA levels was evaluated.
8-br-cAMP increased mRNA levels of MMP-2 when compared to
untreated control MC (Fig. 4) at each timepoint (1 to 24 hr)
studied.
Nuclear run off transcription analysis of PGE2 effects on MMP-2
transcription
To study whether PGE2 directly effects transcription of the
MMP-2 gene in rat MC, nuclear run off experiments were
Table 1. Densitometric analysis of the Northern blot hybridizations
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conducted. In this assay the elongation of nascent RNA was
measured in intact cell nuclei derived from MC which were
incubated for one hour with 2 iM PGE2 or control medium. The
run off assays revealed that 2 iM PGE2 stimulated the transcrip-
tion of MMP-2 RNA compared to untreated control MC (Fig. 5).
In contrast, transcription of the housekeeping gene glycetylaldehyd-
3-phosphate-dehydrogenase (GAPDH) remained unchanged, and
almost no hybridization was detectable with the Bluescript vector as
a negative hybridization control (Fig. 5).
Western blot analysis and zymography of MC culture supernatants
Since PGE2 strongly stimulates RNA expression of MMP-2, we
were interested in whether this stimulation is also reflected in an
increase in MMP-2 protein content and enzyme activity. To
address this question, the amount of MMP-2 protein and the
corresponding enzyme activity was examined by using conditioned
Fig. 4. The cAMP analogue 8-br-cAMP (1 mM)
stimulates MMP-2 steady-state mRN.4 levels of
MMP-2 at 3.1 kb beginning at one hour up to 24
hours compared to untreated control MC.
Fig. 5. Representative results of a Nuclear nm off
transcntion after one hour incubation of
cultured rat MC with PGE2 (2 pM) compared to
untreated controls. PGE2 stimulates elongation
of nascent MMP-2 RNA in isolated nuclei
whereas the house keeping gene GAPDH
remains unaltered. In addition, almost no
hybridization is detectable with the BS-vector as
a negative hybridization control.
media of confluent and quiescent rat MC, which were incubated
for 4 and 16 hours with or without 2 jIM PGE2 under serum-free
conditions (Figs. 6 and 7). The Western blot data depicted in
Figure 6 and Table 2 show that 2 jIM PGE2 increases extracellular
MMP-2 protein content at both time points studied. To examine
whether this PGE2 dependent rise in MMP-2 protein content
leads to an increase of enzyme activity zymographies were per-
formed. Corresponding to the Western blots the extracellular
MMP-2 enzyme activity of PGE2 (2 JIM) treated MC supernatants
increased (Fig. 7).
Discussion
The development of glomerulosclerosis, as a common end point
of different types of chronic glomerulopathies, is characterized by
an accumulation of extracellular matrix and a permanent loss of
glomerular function. Collagen types I, III, IV, laminin and
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ITable 2. Densitometric analysis of the Western blots
Concentration
Time
hours
x-fold vs.
control
PGE2 2 x 106 M 4 5.8 0.2
PGE2 2 x 10-6 M 16 3.5 0.3
Values are depicted as x-fold versus control; data are means so. The
experiment was performed three times. Compare with Figure 6.
fibronectin are all part of the material that is deposited in the
extracellular glomerular space [30, 31]. Numerous studies in
several models of glomerulonephritis have demonstrated that MC
play a prominent role in the development of glomerular scarring
[reviewed in 13]. Since MC also express enzymes that are impor-
tant in the turnover of extracellular matrix proteins [18, 19], it is
crucial to study factors that may influence the activity of these
proteinases.
In the present report we have studied the effect of exogenous
PGE2 on steady-state mRNA levels, transcription, extracellular
protein content and enzyme activity of MMP-2 in cultured rat
MC. Our results demonstrate that POE2 strongly stimulates
MMP-2 steady-state mRNA levels beginning at one hour up to 16
hours. At later timepoints the POE2 effect attenuates and reaches
control levels at 48 hours. The cyclooxygenase inhibitor indometh-
acm did not significantly influence MMP-2 steady-state mRNA
levels. Thus, the effect on MMP-2 mRNA expression depends on
the exogenous stimulation with POE2. Furthermore, POE2 in-
creases new transcription of MMP-2 mRNA as measured by
nuclear run off assays.
To examine which signal transduction pathway is responsible,
we decided to evaluate the possible role of cAMP, since many
PGE2 effects are mediated through generation of cAMP [32, 331
after binding to EP2- and/or EP4-receptors [34]. Our data re-
vealed that 8-br-cAMP increases steady-state mRNA levels of
MMP-2 up to 24 hours. Although we have not directly studied the
effect of cAMP on MMP-2 gene transcription, the 1.7 kb 5'
regulatory region of the translational startsite of the rat MMP-2
gene contains three putative binding sites for the transcription
factor AP-2 [25]. The transcription factor AP-2 is induced by
cAMP. Thus, POE2 might stimulate MMP-2 transcription with
cAMP as a second messenger.
The PGE2-stimulated increase in MMP-2 gene transcription
was also reflected by stimulated protein secretion and enzyme
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Fig. 6. PGE2 (2 psI) stimulates MMP-2 protein Secretion after 4 and 16 hours when assessed by Western blotting using a rabbit anti-MMP-2 antiserum.
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Fig. 7. Zymography of MC supernatant in an
8% polyac,ylamide/SDS gel containing 1 mg/mI
46 gelatine as a substrate. The gelatin digestion
zones represent activated MMP-2. PGE2 (2 pM)
stimulates MMP-2 enzyme activity after 4 and
16 hours when compared to untreated control
supernatant.
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